Latest Scaar Stories

2012-01-09 12:39:58

New generation drug-eluting stents associated with lower rates of mortality and restenosis than bare metal stents A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has found that PCI implantations using a new generation of drug-eluting stents is associated with lower rates of relapse (restenosis), stent thrombosis and subsequent mortality than older generation drug-eluting stents...

2011-08-30 15:56:14

A report from the nationwide complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR) Results from the SCAAR study, presented at the ESC Congress 2011 today, showed that Percutaneous Coronary Intervention (PCI) with "new generation" Drug Eluting Stents, was associated with a 38% lower risk of clinically meaningful restenosis and a 50% lower risk of stent thrombosis compared to old generation DES. Although many trials and studies support the overall early and mid-term...

2011-05-12 08:00:00

HONG KONG, May 12, 2011 /PRNewswire/ -- OrbusNeich today announced that data from multiple studies of the Genous Stent will be presented at EuroPCR 2011 in Paris. Clinical studies supporting the use of the Genous Stent and its endothelial progenitor cell (EPC) capture technology in cases where prolonged dual antiplatelet therapy is not advisable will be presented during the HEALING Symposium and in the scientific sessions. HEALING Symposium The HEALING Symposium, also titled "How to...

2011-04-19 06:00:00

Investigator-initiated European multicenter trial of 1,000 acute heart attack patients will examine the ability of cyclosporine to protect cardiac tissue LUND, Sweden, April 19 /PRNewswire/ - NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM )cremophor-free IV cyclosporine formulation is used in...

2010-10-11 10:54:00

HONG KONG, Oct. 11 /PRNewswire/ -- OrbusNeich today reported the completion of patient enrollment in a randomized clinical study of its Genous Bio-engineered R stent at 11 sites in China. The primary objective of the 180 patient, controlled study is to demonstrate the safety and effectiveness of the Genous Bio-engineered R stent compared to the Medtronic Endeavor® Sprint stent in patients with symptoms of angina or myocardial ischemia. The primary endpoints are difference...

2010-10-05 10:54:00

TORONTO, Oct. 5 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Canadian interventional cardiology device market is a highly competitive and dynamic market, with a small number of large competitors fighting for market share in this extremely profitable area. As of 2010, the drug-eluting stent segment represented a $55 million market -- the most lucrative of the interventional cardiology device markets....

2010-09-25 11:00:00

PHILADELPHIA, Sept. 25 /PRNewswire/ -- Research presented today at the 15th Annual Scientific Session of the American Society of Nuclear Cardiology confirms that stress perfusion imaging and noninvasive angiography provide important data to physicians managing patients with coronary artery disease (CAD). According to results from the SPARC (Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in CAD) trial, SPECT, PET, and 64-slice coronary CT angiography (CCTA) all achieve...

Word of the Day
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.